IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
Bond Avillion 2 Development LP
Kim A Papp; Mark A Weinberg; Alun Morris; Kristian Reich